SG11201700290SA - Biomarkers of polycystic kidney disease and uses thereof - Google Patents

Biomarkers of polycystic kidney disease and uses thereof

Info

Publication number
SG11201700290SA
SG11201700290SA SG11201700290SA SG11201700290SA SG11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA SG 11201700290S A SG11201700290S A SG 11201700290SA
Authority
SG
Singapore
Prior art keywords
biomarkers
kidney disease
polycystic kidney
polycystic
disease
Prior art date
Application number
SG11201700290SA
Inventor
Oxana Beskrovnaya
Nikolai Bukanov
Sarah Moreno
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of SG11201700290SA publication Critical patent/SG11201700290SA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SG11201700290SA 2014-08-04 2015-08-03 Biomarkers of polycystic kidney disease and uses thereof SG11201700290SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462033031P 2014-08-04 2014-08-04
PCT/US2015/043497 WO2016022500A2 (en) 2014-08-04 2015-08-03 Biomarkers of polycystic kidney disease and uses thereof

Publications (1)

Publication Number Publication Date
SG11201700290SA true SG11201700290SA (en) 2017-02-27

Family

ID=54035292

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700290SA SG11201700290SA (en) 2014-08-04 2015-08-03 Biomarkers of polycystic kidney disease and uses thereof

Country Status (12)

Country Link
US (1) US10871495B2 (en)
EP (1) EP3177932B1 (en)
JP (2) JP6730252B2 (en)
KR (1) KR20170033436A (en)
CN (1) CN106716136B (en)
AU (1) AU2015301278A1 (en)
BR (1) BR112017002003A2 (en)
CO (1) CO2017001596A2 (en)
MX (1) MX2017001648A (en)
RU (1) RU2017106891A (en)
SG (1) SG11201700290SA (en)
WO (1) WO2016022500A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018009879A2 (en) 2015-11-18 2018-11-13 Genzyme Corp biomarker of polycystic kidney disease and its uses
GB201719520D0 (en) * 2017-11-24 2018-01-10 Univ College Cardiff Consultants Ltd Neuroprotectvie peptide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039601D1 (en) 1999-05-24 2008-09-04 Avi Biopharma Inc ANTISENSE AGAINST C-MYC FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE
WO2006012394A1 (en) 2004-07-21 2006-02-02 Tulane University Health Sciences Center Treatment of renal dysfunction and multiple myeloma using pacap compounds
EP1808694A1 (en) 2006-01-17 2007-07-18 Universitätsklinikum Freiburg Method for diagnosing polycystic kidney disease
US20120077263A1 (en) * 2009-06-05 2012-03-29 Mayo Foundation For Medical Education And Research Methods and materials for isolating exosomes
CN102018702B (en) * 2009-09-16 2012-07-18 北京大学 New application of ginkgolide B
EP2622095B1 (en) * 2010-10-01 2016-09-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the progression and treating a chronic kidney disease in a patient
US20130276513A1 (en) * 2010-10-14 2013-10-24 The Regents Of The University Of California Methods for diagnosing and assessing kidney disease
WO2014006093A1 (en) 2012-07-03 2014-01-09 Boletta Alessandra Compounds for use in polycystic kidney disease
MA37975B2 (en) 2012-09-11 2021-03-31 Genzyme Corp Glucosylceramide synthase inhibitors

Also Published As

Publication number Publication date
US10871495B2 (en) 2020-12-22
EP3177932A2 (en) 2017-06-14
CN106716136B (en) 2020-06-23
WO2016022500A2 (en) 2016-02-11
JP2017525955A (en) 2017-09-07
JP6730252B2 (en) 2020-07-29
US20170227551A1 (en) 2017-08-10
EP3177932B1 (en) 2021-07-14
AU2015301278A1 (en) 2017-02-09
CO2017001596A2 (en) 2017-05-19
MX2017001648A (en) 2017-04-27
JP7005695B2 (en) 2022-02-04
BR112017002003A2 (en) 2017-12-12
WO2016022500A3 (en) 2016-04-07
RU2017106891A (en) 2018-09-06
CN106716136A (en) 2017-05-24
KR20170033436A (en) 2017-03-24
RU2017106891A3 (en) 2019-03-14
JP2020170013A (en) 2020-10-15

Similar Documents

Publication Publication Date Title
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL247407B (en) Anti-egfrviii antibodies and uses thereof
EP3140722A4 (en) Characterizing states of subject
GB201401603D0 (en) Biomarkers
GB201420908D0 (en) Biomarkers
HK1231555A1 (en) Biomarker and uses thereof
HK1251877A1 (en) Biomarkers and methods of prediction
IL251001B (en) Anti-il-25 antibodies and uses thereof
SI3524234T1 (en) Solid state forms of sofosbuvir
IL246979A0 (en) Solid state forms of sofosbuvir
IL261906A (en) Biomarkers of proteopathies and uses thereof
SG11201700290SA (en) Biomarkers of polycystic kidney disease and uses thereof
ZA201803035B (en) Biomarker of polycystic kidney disease and uses thereof
GB2544217B (en) Chlorination of sucrose-6-esters
EP3200825A4 (en) Antibodies against pathological forms of tdp-43 and uses thereof
PT3130123T (en) Detection of manipulation of applications
IL249332A0 (en) Solid state forms of sofosbuvir
AU2014904616A0 (en) Biomarkers and uses thereof
GB201418230D0 (en) Construction of surfaces
GB201414267D0 (en) Chlorination of sucrose-6-esters
AU2014901825A0 (en) Biomarker of Disease